## FDS: FactSet Research Systems Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 2.4% below STRENGTH zone (3.0-6.0%); PEG 1.64 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($276.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. FactSet Research Systems Inc. $FDS Holdings Lifted by Azora Capital LP**
- Source: MarketBeat | 20251210T090832 | Neutral | Relevance: 99%
-  Azora Capital LP significantly increased its holdings in FactSet Research Systems Inc. ($FDS) by 74.4% in the second quarter, bringing its total to 58,442 shares worth approximately $26.14 million. Several other institutions also boosted their stakes, contributing to 91.24% institutional ownership. Despite some analyst sentiment cooling to a "Reduce" rating, company insiders made notable share purchases, and FactSet announced a quarterly dividend of $1.10.

**2. California Public Employees Retirement System Decreases Stock Holdings in FactSet Research Systems Inc. $FDS**
- Source: MarketBeat | 20251210T095932 | Neutral | Relevance: 98%
-  The California Public Employees Retirement System significantly reduced its stake in FactSet Research Systems Inc. by 15.0% in the second quarter, selling 24,936 shares and ending the period with 141,006 shares valued at $63,069,000. Other institutional investors showed mixed activity, with some increasing their holdings. Analysts have recently adjusted price targets and ratings for FactSet, currently holding an average "Reduce" rating with an average price target of $346.50.

**3. FactSet Research (FDS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release**
- Source: Yahoo Finance | 20251211T150825 | Bullish | Relevance: 98%
-  FactSet Research (FDS) is expected to report a year-over-year increase in earnings and revenues for the quarter ended November 2025. The company's upcoming earnings report, due December 18, shows a positive Earnings ESP of +1.77% and a Zacks Rank #3, suggesting a strong possibility of beating the consensus EPS estimate. Investors should consider these factors and other business conditions discussed by management.

**4. Arrowstreet Capital Limited Partnership Has $17.04 Million Holdings in FactSet Research Systems Inc. $FDS**
- Source: MarketBeat | 20251209T083517 | Neutral | Relevance: 97%
-  Arrowstreet Capital Limited Partnership increased its stake in FactSet Research Systems Inc. (NYSE:FDS) by 49.4% in the second quarter, reaching a total holding of $17.04 million. Other institutional investors also adjusted their positions, and insider transactions included purchases by EVP Helen L. Shan and EVP Goran Skoko. FactSet Research Systems recently announced a quarterly dividend of $1.10 per share and reported quarterly earnings, with analysts providing various ratings and price targets for the stock.

**5. 4,083 Shares in FactSet Research Systems Inc. $FDS Acquired by iSAM Funds UK Ltd**
- Source: MarketBeat | 20251209T140809 | Neutral | Relevance: 97%
-  iSAM Funds UK Ltd acquired 4,083 shares of FactSet Research Systems Inc. (NYSE:FDS) in the second quarter, valuing the stake at approximately $1.83 million. Institutional investors now hold about 91.24% of FactSet's stock. Despite missing EPS estimates, FactSet reported solid revenue growth and declared a quarterly dividend, though analyst sentiment remains cautious with a "Reduce" consensus rating.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Wells Fargo | $260 | $296 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Wells Fargo | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 24 ($0.23M) |
| Sells | 8 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.1% (+1.2%)
- Ninety One UK Ltd: 6.5% (+102.4%)
- Morgan Stanley: 5.8% (-8.7%)
- State Street Corpora: 5.2% (+1.2%)

### Key Risks

1. Elevated short interest (8.4%): bears positioning against stock.
2. Long-term trend broken: trading 23.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.64 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 29%, ROA 11%, margin 26%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.0B |
| Beta | 0.74 |
| 52W Range | $250.50 - $496.90 |
| Short Interest | 8.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.64 |
| Forward P/E | 15.5 |
| Current P/E | 16.8 |
| YoY Growth | 8.4% |
| EPS Direction | FALLING |

### Technicals

MRS_10 stable at 2.4% (minimal 5-day change). Below STRENGTH zone by 0.6pp (needs >3.0% for momentum thesis). MRS_5 at 0.9% confirms short-term momentum alignment. Below SMA200 (0.77x), long-term trend not supportive. MACD histogram positive (2.24), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.40% (CS: 64) | Neutral |
| RSI_14 | 62.5 | Neutral |
| MACD Histogram | 2.24 | Bullish |
| vs SMA20 | 1.045x | Above |
| vs SMA50 | 1.048x | Above |
| vs SMA200 | 0.768x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $291.55
- **Stop Loss:** $276.39 (5.2% risk)
- **Target:** $306.71 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 91
- **Position Value:** $26,531.05
- **Portfolio %:** 26.53%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2025-12-18 (Est: $4.35)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.13 | $4.05 | -1.9% |
| 2025Q2 | $4.30 | $4.27 | -0.6% |
| 2025Q1 | $4.18 | $4.28 | +2.4% |
| 2024Q4 | $4.28 | $4.37 | +2.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*